Update: HealthSonix Registers AquaSonix Medical Device With the FDA
News Desk
services and FDA registered medical products to treat the pain
associated with arthritis; fibromyalgia; soft tissue and ...
IRVINE, CA -- (MARKET WIRE) -- 06/22/2006 -- HealthSonix Inc.
("HealthSonix" or the "Company") (PINKSHEETS: HSXI)
www.HealthSonix.com, is pleased to announce that it has registered the
AquaSonix medical device with the United States Food and Drug
Administration (FDA). Indications are for pain reduction and muscle
relaxation. The device was designated as class 1, the safest
classification for medical devices.
"Arthritis is the number one cause of chronic pain in North America.
Thirty percent of adult population has been diagnosed with arthritis
and our breakthrough medical technology is very timely with the aging
of the population. This new technology uses sound pressure waves to
stimulate the mechanoreceptors in the body and, when combined with low
impact exercise programs in warm water pools, continues to record
impressive reductions in pain," said Dieter Doederlein, Vice President
of Corporate Development. "To date over $4.5 million has been invested
in Research and Development, testing, clinical work and regulatory
compliance to get to this milestone in our Company's development."
AquaSonix Therapy programs are held throughout the day and early
evening in warm water pools (85 degrees to 94 degrees Fahrenheit)
located in hospitals, rehabilitation clinics, community centers, and
retirement residences. The standard course of therapy is fifteen
45-minute sessions, ideally two to three times a week with a minimum of
one day in between treatment sessions. All programs are led by
certified AquaSonix Therapists.
The sound pressure waves generated by the AquaSonix device are believed
to work by stimulating mechanoreceptors in the skin, which in turn
communicate with the brain and block pain messages from getting through
(gate control theory of pain); and by creating an exercise effect in
the muscles, which encourages the production and release of endorphins,
the body's natural pain killers.
About HealthSonix Inc.
HealthSonix Inc. (PINKSHEETS: HSXI) is a multi-dimensional medical
technology company that develops and markets healthcare services and
FDA registered medical products to treat the pain associated with
arthritis; fibromyalgia; soft tissue and muscular injuries. The
company's offerings are based on patent pending medical technologies
that use sound pressure waves at the core of its treatment protocols.
For more information, please visit www.healthsonix.com or call
1-877-622-2121.
Note: A number of statements contained in this report are
forward-looking statements, which are made pursuant to the Safe Harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements involve a number of risks and
uncertainties, including the timely development and market acceptance
of products and technologies, competitive market conditions, successful
integration of acquisitions, the ability to secure additional sources
of financing, the ability to reduce operating expenses and other
factors not set forth herein. The actual results that the Company may
achieve may differ materially from any forward-looking statements due
to such risks and uncertainties.
Dieter Doederlein
1-877-622-2121
www.healthsonix.com
SOURCE: HealthSonix Inc.
http://www.marketwire.com/mw/release_html_b1?release_id=138292